Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans.

BACKGROUND AND PURPOSE The potentials of lung sparing, dose escalation, and the robustness of intensity modulated proton plans (IMPT(robust)), obtained by minimax optimization on multiple scenarios, were studied. MATERIALS AND METHODS IMPT(robust) optimization as described by Fredriksson et al. [23] was evaluated by means of comparative treatment planning using breath hold CT data from 6 non-small cell lung cancer (NSCLC) patients. IMPT(robust) and single field uniform dose (SFUD) proton plans were compared to Tomotherapy and 7-field intensity modulated photon therapy (IMXT). Plan robustness against set-up errors, range uncertainties, and between field motions were analyzed as well as lung exposure quantified by the mean lung dose (MLD) and the partial lung volumes receiving at least 20, 10, and 5 Gy(RBE) (V20, V10, V5). Robustness was analyzed with regard to stability of the effective uniform dose (EUD) and the dose level reached or exceeded in 95% of the CTV (D95). RESULTS MLD by IMPT(robust) was less than by SFUD, and Tomotherapy in each patient, on average by 14.8% and 28.5% (p<0.05, Friedman test). V20-V5 were higher with Tomotherapy compared to both proton therapy techniques, on average by a factor of >1.8. Robustness of IMPT(robust) was high. EUD and D95 values were maintained above 96% and 94% of the reference plan values for all tested scenarios. With dose escalation to 86 Gy(RBE) lung tissue tolerances were maintained. CONCLUSIONS IMPT(robust) proved advantageous in terms of lung exposure and possible dose escalation while being also markedly robust. However, motion during delivery of a field remains a major problem of IMPT(robust) to be mitigated by high scanning speed and variable spot size.

[1]  Harald Paganetti,et al.  Proton vs carbon ion beams in the definitive radiation treatment of cancer patients. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  Joao Seco,et al.  Treatment of non-small cell lung cancer patients with proton beam-based stereotactic body radiotherapy: dosimetric comparison with photon plans highlights importance of range uncertainty. , 2012, International journal of radiation oncology, biology, physics.

[3]  Icru.  Prescribing, recording, and reporting photon beam therapy , 1993 .

[4]  Joe Y. Chang,et al.  Phase 2 study of high‐dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer , 2011, Cancer.

[5]  Y. Ung,et al.  Reproducibility of lung tumor position and reduction of lung mass within the planning target volume using active breathing control (ABC). , 2003, International journal of radiation oncology, biology, physics.

[6]  Eike Rietzel,et al.  Four-dimensional proton treatment planning for lung tumors. , 2006, International journal of radiation oncology, biology, physics.

[7]  Hugh Calkins,et al.  Changes of Pulmonary Vein Orifice Size and Location throughout the Cardiac Cycle: Dynamic Analysis Using Magnetic Resonance Cine Imaging , 2005, Journal of cardiovascular electrophysiology.

[8]  M. Martel,et al.  Radiation dose-volume effects in the lung. , 2010, International journal of radiation oncology, biology, physics.

[9]  Joe Y. Chang,et al.  4D Proton treatment planning strategy for mobile lung tumors. , 2007, International journal of radiation oncology, biology, physics.

[10]  Zuofeng Li,et al.  Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: technique and early results. , 2012, Clinical lung cancer.

[11]  H. Tsujii,et al.  ICRU Report No. 78, Prescribing, recording, and reporting proton-beam therapy. , 2007 .

[12]  Shinichiro Mori,et al.  Effects of intrafractional motion on water equivalent pathlength in respiratory-gated heavy charged particle beam radiotherapy. , 2007, International journal of radiation oncology, biology, physics.

[13]  Lei Dong,et al.  A beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties. , 2012, International journal of radiation oncology, biology, physics.

[14]  D Robertson,et al.  Intensity modulated proton therapy treatment planning using single-field optimization: the impact of monitor unit constraints on plan quality. , 2010, Medical physics.

[15]  Zuofeng Li,et al.  Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric study. , 2011, Clinical lung cancer.

[16]  Alfons G H Kessels,et al.  Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  Christoph Bert,et al.  Gated irradiation with scanned particle beams. , 2009, International journal of radiation oncology, biology, physics.

[18]  Jose Belderbos,et al.  Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  G. Hommel.  A stagewise rejective multiple test procedure based on a modified Bonferroni test , 1988 .

[20]  Daniel Gomez,et al.  Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study. , 2011, International journal of radiation oncology, biology, physics.

[21]  D Meer,et al.  A study on repainting strategies for treating moderately moving targets with proton pencil beam scanning at the new Gantry 2 at PSI , 2010, Physics in medicine and biology.

[22]  J. Jett,et al.  Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer. , 2005, International journal of radiation oncology, biology, physics.

[23]  Steve B. Jiang,et al.  Effects of intra-fraction motion on IMRT dose delivery: statistical analysis and simulation. , 2002, Physics in medicine and biology.

[24]  Richard Symonds-Tayler,et al.  The use of the Active Breathing Coordinator throughout radical non-small-cell lung cancer (NSCLC) radiotherapy. , 2011, International journal of radiation oncology, biology, physics.

[25]  B. Min,et al.  Secondary radiation doses of intensity-modulated radiotherapy and proton beam therapy in patients with lung and liver cancer. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  T. Gauler,et al.  Intensified high-dose chemoradiotherapy with induction chemotherapy in patients with locally advanced non-small-cell lung cancer-safety and toxicity results within a prospective trial. , 2010, International journal of radiation oncology, biology, physics.

[27]  V. Rusch,et al.  Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial , 2009, The Lancet.

[28]  Joe Y. Chang,et al.  Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer , 2011, Cancer.

[29]  Tae Hyun Kim,et al.  Treatment-related pneumonitis and acute esophagitis in non-small-cell lung cancer patients treated with chemotherapy and helical tomotherapy. , 2010, International journal of radiation oncology, biology, physics.

[30]  Frank Verhaegen,et al.  Results of a Multicentric In Silico Clinical Trial (ROCOCO): Comparing Radiotherapy with Photons and Protons for Non-small Cell Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[31]  Daniel W. Miller,et al.  Methodologies and tools for proton beam design for lung tumors. , 2001, International journal of radiation oncology, biology, physics.

[32]  Radhe Mohan,et al.  Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer. , 2006, International journal of radiation oncology, biology, physics.

[33]  G J Kutcher,et al.  Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation. , 1999, International journal of radiation oncology, biology, physics.

[34]  Radhe Mohan,et al.  Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study. , 2010, International journal of radiation oncology, biology, physics.

[35]  A. Niemierko.  Reporting and analyzing dose distributions: a concept of equivalent uniform dose. , 1997, Medical physics.

[36]  G Kraft,et al.  Design and construction of a ripple filter for a smoothed depth dose distribution in conformal particle therapy. , 1999, Physics in medicine and biology.

[37]  C. Xie,et al.  Dosimetric comparison between helical tomotherapy and intensity‐modulated radiation therapy plans for non‐small cell lung cancer , 2011, Chinese medical journal.

[38]  Anders Forsgren,et al.  Minimax optimization for handling range and setup uncertainties in proton therapy. , 2011, Medical physics.

[39]  Mike Partridge,et al.  Dose escalation for non-small cell lung cancer: analysis and modelling of published literature. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[40]  J. Fowler,et al.  A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117. , 2010, International journal of radiation oncology, biology, physics.

[41]  Marianne C Aznar,et al.  Estimated radiation pneumonitis risk after photon versus proton therapy alone or combined with chemotherapy for lung cancer , 2011, Acta oncologica.

[42]  M. V. van Herk,et al.  Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. , 2002, International journal of radiation oncology, biology, physics.

[43]  Hiroki Shirato,et al.  STEREOTACTIC RADIATION THERAPY WORKSHOP Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study , 2007 .